PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer

Folia Histochemica et Cytobiologica

Volumn 48, Issue 4, 2010, Pages 632-636

  Pryczynicz, Anna ^a   Guzińska Ustymowicz, Katarzyna ^a   Chang, Xiao Jia ^b   Kiśluk, Joanna ^a   Kemona, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Attogen Biomedical Research   (Poland)

Author keywords

Gastric cancer; PRL 3; Protein tyrosine phosphatase type IVA member 3; PTP4A3

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE TYPE IV A MEMBER 3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFUSED TYPE CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; POORLY DIFFERENTIATED MUCOID CARCINOMA; PRIMARY TUMOR; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 79958068171     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.2478/v10042-010-0070-7     Document Type: Article

References (23)

1. Didkowska J, Wojciechowska U, Tarkowski W, Zatoński W. Nowotwory złośliwe w Polsce w 2005 roku, Centrum Onkologii-Instytut, Warszawa, 2007.
2. Bessette DC, Qiu D, Pallen CJ. PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev. 2008;27:231-252.
3. Kim KA, Song JS, Jee J, et al. Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett. 2004;565: 181-187.
4. Zeng Q, Si X, Horstmann H, Xu Y, Hong W, Pallen C. J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2 and -3 with the plasma membrane and the early endosome. J Biol Chemistr. 2000;275:21444-21452.
5. Matter WF, Estridge T, Zhang C, et al. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun. 2001;283:1061-1068.
6. Wu X, Zeng H, Zhang X, Zhao Y, et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol. 2004;164:2039-2054.
7. Guo K, Li J, Wang H, et al. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res. 2006;66:9625-9635.
8. Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of Colorectal cancer. Science. 2001;294:1343-1346.
9. Polato F, Codegoni A, Fruscio R, et al. PRL-3 phosphatases is implicated in ovarian cancer growth. Clin Cancer Res. 2005;11:6835-6839.
10. Wang L, Peng L, Dong B, et al. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol. 2006;17:1517-1522.
11. Miskad UA, Semba S, Kato H, Yokozaki H. Expression of PRL-3 phosphatase in human gastric carcinoma: close correlation with invasion and metastasis. Pathobiology. 2004;71: 176-184.
12. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;64:31-49.
13. Goseki N, Takizawa T, Koike M. Differences in the mode of extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut. 1992;33:606-612.
14. Borrmann R. Geshwulste des Magens und Duodenums. In: Henker F, Lubarsh D. Handbuchder Spezieller Pathologischen, Volume IV, Anatomie und Histolgie Berlin: Springer-Verlag 865; 1926.
15. Kubo M, Sasako M, Gotoda T, et al. Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer. 2002;5: 83-89.
16. Peng L, Ning J, Meng L, Shou C. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol. 2004;130: 521-526.
17. Miskad U.A, Semba S, Kato H, et al. High PRL-3 expression in human gastric cancer is a marker of metastasis and gradem of malignancies: an in situ hybidization study. Virchows Archiv. 2007;450: 303-310.
18. Li ZR, Wang Z, Zhu BH, et al. Association of tyrosine PRL-3 phosphatase protein expresson with peritoneal metastasis of gastric carcinoma and prognosis. Surgery Today. 2007;37: 646-651.
19. Wang Z, He YL, Cai SR, et al. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Int J Cancer. 2008;123: 1439-1447.
20. Wang Z, Cai SR, He YL, et al. High Expression of PRL-3 can Promote Growth of Gastric Cancer and Exhibits a Poor Prognostic Impact on Patients. Ann Surg Oncol. 2008 Nov 14. [Epub ahead of print]
21. Kato H, Semba S, Miskad UA, Seo Y, Kasuga M, Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in huma colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clinical Cancer Research. 2004;10:7318-7328.
22. Wang Y, Li ZF, He J, et al. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis. 2007;22: 1179-1184.
23. Cai SR, Chen CQ, Wang Z, et al. Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation. Zhonghua Yi Xue Za Zhi. 2008;88: 2326-3230.